Book a demo

Chemical intelligence powered by cypris.ai

1H-imidazol-2-yl (2S)-2-amino-3-(1H-imidazol-5-yl)propanoate

1H-imidazol-2-yl (2S)-2-amino-3-(1H-imidazol-5-yl)propanoate

FormulaC9H11N5O2
Mol. weight221.22
PubChem CID57046064
InChIKeyNQZRBPJAHUOTAF-ZETCQYMHSA-N
SMILESC1=CN=C(N1)OC(=O)[C@H](CC2=CN=CN2)N
379Patents
63Research papers
12Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1United States Department of Health and Human Services22
2Battelle Energy Alliance LLC17
3Danisco US Inc14
4F Hoffmann La Roche AG13
5Merck and Co Inc12
6Roche Diagnostics GmbH10
7Yeda Research and Development Co Ltd10
8Lipotec SA8
9Cellectar Biosciences Inc6
10CS Pharmatech Ltd5

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C07KPeptides154
2A61KMedicinal preparations146
3A61PTherapeutic activity (drug indications)121
4G01NInvestigating / analysing materials90
5C12NMicroorganisms, enzymes74
6C07DHeterocyclic compounds52
7C12QMeasuring/testing involving enzymes41
8C12PFermentation, enzyme processes31
9C07CAcyclic and carbocyclic compounds22
10C12YEnzyme nomenclature (EC numbers)21

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Crystallography and molecular interactions1
2Enzyme Structure and Function1
3Trace Elements in Health1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1F. Ann WalkerUniversity of Arizona3
2Anthony R. ClarkeUniversity College London2
3C. Jeremy CravenUniversity of Sheffield2
4Glenn L. MillhauserUniversity of California, Santa Cruz2
5Graham S. JacksonUniversity College London2
6Huilu WuLanzhou Jiaotong University2
7John CollingeUniversity College London2
8Jonathan P. WalthoUniversity of Sheffield2
9Laszlo L. P. HosszuUniversity of Sheffield2
10M A WellsUniversity of Sheffield2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition of this compound?

The compound 1H-imidazol-2-yl (2S)-2-amino-3-(1H-imidazol-5-yl)propanoate has a molecular formula of C9H11N5O2 and a molecular weight of 221.22. Its InChI Key is NQZRBPJAHUOTAF-ZETCQYMHSA-N.

How much patent activity covers this compound?

There are 379 total patents covering this compound, with 12 patents filed in the last 3 years. The most active period was 2018, which had 21 patents.

Which organizations hold the most patents related to this compound?

The United States Department of Health and Human Services holds the most patents with 22 filings, followed by Battelle Energy Alliance LLC with 17 patents and Danisco US Inc with 14 patents. Other significant patent holders include F Hoffmann La Roche AG with 13 patents and Merck and Co Inc with 12 patents.

What are the main patent classification areas for this compound?

The leading patent classification areas are peptide-related inventions under C07K (154 patents), pharmaceutical preparations under A61K (146 patents), and therapeutic applications under A61P (121 patents). Analytical and diagnostic patents also feature prominently under G01N (90 patents).

What research topics are associated with this compound?

The research literature covers topics including trace elements in health, enzyme structure and function, and crystallography and molecular interactions. Notably, published research has focused on copper binding interactions and histidine coordination in the context of prion proteins and neurodegenerative diseases.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial